top of page

Centene Corporation (XNYS:CNC) In-Depth Stock/Fundamental/Options Analysis Today

Primary Facts

CNC

Name:

CENTENE CORPORATION (XNYS:CNC)

Sector:

909.00M

Industry:

Healthcare Plans

CEO:

Mr. Michael Neidorff

Total Employees:

72,500

Our Technological Advancement Rating

Our Rating:

D

Technological advancement compared to industry is -152.36% lower

ANALYSIS OF ALL CRITICAL FACTORS & RISKS RELATED TO THE STOCK & FUNDAMENTAL/LONG-TERM ANALYSIS OF CENTENE CORPORATION(CNC) AS PER DATA ANALYSIS OF LAST 3 YEARS AND COMPARISON WITH COMPETITORS/PEERS, AND HEALTHCARE PLANS INDUSTRY. DATE: 07/09/2022

Primary Targets/Price Insights

Previous Close ($) :

90.05

One Month Price Target:

$90.31

Six Month Price Target :

$91.6

Likely Price in One Year's Time:

Ticker:

$93.16

Likely Trading Range Today Under (Normal Volatility)
 

$89.74

Price Upper limit ($) :

$90.53

Price Lower limit ($) :

Crash Risk Prep/Key Price Levels (High Volatility/Risk)

Price, as per data analysis, isn't likely to fall below:

Today:

$85.39

                                                               This week:

$79.64

                                                        This month :

$69.22

Other Primary facts

Market Cap:

50.49B

Market Cap Classification:

Large Cap

Number of Shares

IPO Date:

571.58M

Best/Worst Daily Performance (Last 3+ Years)
 

Highest Daily Appreciation:

15.6%

-15.01%

Worst Daily Decline:

Our Options Trading Entry Points

Iron Condor entry points for options expiring in 1 week's time

Low risk (<2%) entry points

Buy Call:

Sell Call:

Buy Put:

Sell Put:

$111.65

$101.64

$68.45

$78.46

Medium risk (<10%) entry points

Buy Call

Sell Call

$98.38

Buy Put:

Sell Put:

$96.24

$81.70

$83.86

These entry points can be used for other strategies, such as butterflies, straddles, etc.

Risk-Adjusted returns (Sharpe Ratio) of

CNC

Sharpe Ratio:

3.37%

Comparison:

CNC, is amongst the top 20% stocks with highest risk-adjusted returns

Sharpe ratio is -14.67% lower than the industry

& ratio is 47.64% higher than the market/S&P 500 average

Average Returns/Yield of

CNC

Daily returns:

0.10%

Weekly returns:

0.48%

Monthly returns:

1.90%

Yearly returns:

24.40%

Comparison of returns:

Average annual returns/yield (last 3 years) is -6.41% below industry average

Classification:

CNC, is amongst the top 40% highest yielding stocks in terms of daily returns

Results of T-Test of Returns:

0.99

Statistical test of Returns:

CNC has not yielded statistically significant higher returns when compared to the market

SHARPE ratio explained.png

Volatility (measured by Standard Deviation)

Daily Volatility:

2.56%

Weekly Volatility:

5.73%

Monthly Volatility:

11.47%

Yearly Volatility:

39.73%

Volitlilty of last five days (Measured by Standard Deviation) 

Average Volatility of this Week:

1.48%

Volatility in last five trading days has been -42.44% below long-term volatility

Value at Risk Analysis (VaR)

Daily VaR:

-5.17%

Weekly VaR:

-11.57%

Monthly VaR:

-23.13%

How Much Can the price of

CNC

Decline in a Recession?

Likely price decline in a recession: 

Base case (decline):

-19%

Worst case (decline):

-80.12%

This translates to price declining to:

$72.62

This translates to price declining to:

$17.90

Severe Crash Probability

Risk of crash in next 6/12 months: Very high (>70%)

What is Value at Risk (VaR)?

VaR explained figure

Risk Fundamentals

CNC is a 63.25% riskier investment compared to the market/S&P 500 & is 39.86% riskier than Nasdaq (IXIC)

Risk (measured by volatility) is 10.21% above industry average

Overall, it is amongst the top 50% most risky stocks

Beta Examination of

CNC

Beta in relation to market/S&P 500--0.51

Expected beta in 1 year's time:

0.635

Expected beta in 3 year's time:

0.898

Unlevered (debt free) Beta:

0.321

Beta in relation to Nasdaq (XNAS):

0.655

Beta in relation to all global stocks::

0.885

Beta Comparison & Analysis

Beta of competitors/peers::

0.848

Beta is -39.41% lower than peers

Average Industry Beta: 

0.719

Beta is -28.58% below industry average

Sustainable Growth Rate Analysis

Sustainable growth rate for this stock/firm:

5.08%

Sustainable growth rate is -65.28% below industry average

Alpha provided | Alpha Analysis 

Alpha provided:

0.162

Alpha is -0.95% below industry average alpha yield

Alpha is 1029% higher than market/& is unsustainably high

Analysis of Cost of Capital of

CNC

Equity cost of capital:

0.067

Equity cost of capital is -17.43% below industry mean WACC

Unlevered (without debt) cost of capital:  

4.16%

Before-tax cost of debt:

2.89%

After-tax cost of debt:

2.28%

Overall debt rating:

High AA grade (second highest grade)

Weighted average cost of capital (WACC):

2.28%

WACC is -18.66% below industry mean WACC

Key Per-Share Metrics & Analysis

Revenue per share:

$233.01

Revenue growth rate per share of (3Y):

1.88

Annual revenue growth rate is -43.78% below industry average

EPS:

$2.52

Expected Annual growth rate of  EPS (3Y):

-10.59%

Expected future EPS growth rate is -202.41% lower than the Healthcare Plans industry

Free cash flow (FCF) per share:

$7.32

-

-

Debt per share

$38.78

EBITDA per share

$7.32

Valuation Analysis Today of

CNC

P/E Ratio:

28.64

P/E Ratio of Competitors/Peers:

41.66

P/E ratio is -31.25% lower than main peers & is 30.39% higher than the industry

Stock price/value with industry average P/E ratio: $55.36

CNC is 62.67% overvalued if valued using industry average P/E ratio

-

-

P/S (Price to Sales ratio):

0.39

Price to sales ratio is -50.27% below the industry mean

P/B (Price to book value ratio):

1.88

Price to free cash flow: 12.31

Price to free cash flow ratio is -19.72% lower than the industry

Net income growth rate (3Y):

0.21%

Net income growth rate is -100.26% lower than the industry average net income growth rate

Dividend Analysis

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Dividend History:

--$0.00

--$0.00

--$0.00

--$0.00

--$0.00

--$0.00

-

In-depth Debt & Leverage Analysis

Debt to equity ratio:

81.59%

Net debt to equity ratio:

42.08%

Debt to assets ratio:

26.74%

Net debt to assets ratio:

13.79%

Debt-to-asset ratio is -58.58% below industry average

Ability to repay debt:

Interest coverage ratio:

6.39

Interest coverage ratio is 116.22% more than industry average

Looking forward:

Debt growth rate:

2.84%

Annual debt growth is -99% lower than industry average debt growth rate

Debt repayment rate in last quarter: 2.43%

Analysis of Key Statistics  

Correlation of price movement with the market:

0.577

Statistical significance of correlation:

CNC has a statistically significant correlation with the market

Average Correlation of  the industry with the market:

0.624

Stock price is -7.52% less correlated with the market compared to the industry average correlation

R Squared (percentage of price movement explained by movement of the market): 

0.624

Correlation of price movement with Nasdaq (^IXIC):

0.016

Covariance  of price movement with the market:

0.024

Kurtosis 

5.94

Returns have moderate fat-tails (leptokurtic), i.e., returns considerably higher or lower than the mean returns are more probable, compared to assets with normally distributed returns

Skewness of returns:

0.359

Returns are, approximately, symmetrical

Fundamental Analysis & Dupont Analysis of

CNC

Gross Profit Margin Ratio:

45%

Operating Profit Margin Ratio:

1.49%

Operating profit margin is -150.23% lower than the industry

Net Profit Margin Ratio:

45%

Effective Tax Rate:

26.19%

Effective tax rate is 57.34% higher than the industry

Dupont Method

Net Profit Margin

Return on Equity Ratio (ROE):

×

ROA

=

×

5.51%

Return on equity (ROE) is -164.37% lower than the industry

Financial Leverage

Asset Turnover Ratio (ROA):

1.81%

Return on assets (ROA) is -146.80% lower than the industry

Financial Leverage:

1.4x

Current Ratio:

1.05

Current ratio is -36.70% below industry average

Cash Conversion Cycle (days):

0

-

The remaining useful life of property plant & equipment is: 1.8 years

Stock based compensation to net income ratio:

4.68%

In-depth Efficiency  Analysis

Revenue generated per employee:

1.8M

Each employee generates 22% more revenue than industry average revenue per employee

EBITDA generated per employee: 

57.7K

Each employee generates -26% less EBITDA than industry average revenue per employee

Profit generated per employee: 

20.6K

Each employee generates -51% less net income/profit than industry average revenue per employee

Free cash flow (FCF) generated per employee: 

12.5K

Each employee generates -9% less free cash flow than industry average revenue per employee

Assets/Capital per employee

714.4K

Each employee generates -9% less free cash flow than industry average revenue per employee

Research & Development (R&D) Analysis

-

-

Competitors/Peer firms of 

CNC

AGILENT TECHNOLOGIES, INC. (XNYS:A)

BAXTER INTERNATIONAL INC. (XNYS:BAX)

Takeda Pharmaceutical Company Limited (XNYS:TAK)

IQVIA HOLDINGS INC (XNYS:IQV)

Alcon Inc. (XNYS:ALC)

MCKESSON CORPORATION (XNYS:MCK)

VEEVA SYSTEMS INC. (XNYS:VEEV)

METTLER-TOLEDO INTERNATIONAL INC. (XNYS:MTD)

RESMED INC. (XNYS:RMD)

Current Analyst Ratings

Strong buy�21%

Buy�29%

Hold�21%

Sell�0%

Strong sell�0%

Overall analyst sentiment is: Buy

Income Statement

Period:

TTM

Date:

3/31/22

Revenue:

133.18B

Cost of Revenue:

Gross Profit:

R&D Expense

General & Admin Expenses:

Selling, General & Admin Expenses

Sales and Marketing Expenses

Other Expenses :

Operating Expenses :

Cost & Expenses :

Interest Income:

Interest Expenses:

Depreciation & Amortization:

EBITDA:

Operating Income:

Other Income Expenses:

Income Before Tax:

Income Tax Expense:

Net Income:

Balance Sheet

Date:

Calendar Year:

Period:

Cash & Cash Equivalents:

Short Term Investments:

Cash & Short Term Investments:

Net Receivables:

Inventory:

Other Current Assets:

Total Current Assets:

PP&E:

Goodwill: 

Intangible Assets: 

Long Term Investments: 

Tax Assets: 

Other Non-Current Assets: 

Total Non-Current Assets: 

Other Assets: 

Total Assets: 

Accounts Payable: 

Short Term Debt:

Tax Payables:

Deferred Revenue:

Other Current Liabilities:

Total Current Liabilities:

Long Term Debt:

Other Non-Current Liabilities:

Total Non Current Liabilities:

Other Liabilities:

Total Liabilities:

Common Stock:

Retained Earnings:

Accumulated Other Comprehensive Loss:

Other Total Stockholders' Equity:

Total Stockholders' Equity:

Total Liabilities and Stockholders' Equity:

Total Investments:

Total Debt:

Net Debt:

118.25B

14.94B

-

10.54B

10.54B

-

930.00M

11.47B

-

655.00M

1.51B

4.19B

1.98B

1.50B

2.02B

529.00M

1.50B

Statement of Cash Flow

Date:

Period:

390.00M

Differed Income Tax :

12.00M

Stock Based Compensation :

70.00M

Change in Working Capital :

- 192000.00K

Accounts Receivables:

- 3099000.00K

Other Working Capital:

81.00M

Other Non-Cash Items:

19.00M

Net Cash Provided by Operating Activities:

1.15B

Investments in PP&E:

-

Net Acquisitions:

- 1504000.00K

Purchases of Investments:

- 1700000.00K

Sales/Maturities of Investments:

Other Investing Activities:

​Net Cash Used for Investing Activities:

Debt Repayment:

Common Stock Issued:

Common Stock Repurchased:

Dividend Paid:

Other Financing Activities:

Net Cash Used Provided by Financing Activities:

Effect of FOREX on Changes in Cash:

Net Changes in Cash:

Cash at End of Period:

Cash at Beginning of Period:

Operating Cash Flow:

Capital Expenditure:

Free Cash Flow (FCF):

3/31/22

2022

Q1

11.24B

1.67B

12.91B

16.17B

-

2.04B

31.11B

7.07B

20.90B

8.14B

14.13B

-

1.55B

51.79B

-

82.90B

9.77B

502.00M

-

526.00M

18.89B

29.69B

22.17B

2.44B

25.90B

-

55.59B

1.00M

8.99B

- 485000.0K

18.67B

March 31, 2022 at 6:00:00 AM

129.72B

27.17B

82.76B

15.80B

22.67B

11.4B

1.05B

- 244000.00K

- 2401000.00K

- 553000.00K

-

- 71000.00K

-

126.00M

- 498000.00K

33.00M

- 1715000.00K

11.50B

13.21B

1.15B

- 242000.00K

909.00M

Our Proprietary Portfolio Rating

Our Rating:

B

Portfolio rating_explained.png
Tech rating_explained.png
Alpha explained.png

Price Forecast/Expected Price in Next 5 Years of

CNC

2023

2024

2025

2026

2027

$97.83

$101.20

$104.70

$108.31

$112.05

Woman Climber

SUPPORT US ON PATREON! 

Subscribe to stay updated on emerging risks and trends, so your capital, portfolio, and positions are protected!​

Thanks for submitting!

©Risk Concern 2022. All Rights Reserved. 
Risk Disclaimer: Trading in financial markets and cryptocurrencies is a risky activity and includes the risk of losing some, or all, of your investment amount. It is not suitable for all investors. The reports and data provided by risk concern are for informational purposes only. Risk concern and all associated with it shall not be responsible for any losses caused by the information or viewpoints presented on risk concern.

Risk Concern 16A Avenue, Edmonton, Alberta, Canada (T6w1Y2)

bottom of page